Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

NVO AGN TEVA ENDP 
Benchmark  United States  NYSE  11,082   35.82 Index Moved Down -0.32%  


Processing
Processing. Please wait...

Amarin Probability Of Bankruptcy Amarin Probability Of Bankruptcy

For stocks, Probability Of Bankruptcy is normalized value of Z-Score. For funds and ETFs it is derived from a multi-factor model developed by Macroaxis.The score is used to predict probability of a firm or a fund going into bankruptcy or experiencing financial distress within next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100 indicating the actual probability the firm will be distressed in the next 2 fiscal years.
Amarin 
Probability Of Bankruptcy 
 = 
Normalized 
 
Z-Score 
 = 
93.59 %

About Probability Of Bankruptcy

Companies or funds with Probability Of Bankruptcy above 90% are generally considered to be high risk with a good chance of bankruptcy in the next 2 years. On the other hand entities with Probability Of Bankruptcy of less than 15% will most likely experience some growth in the next 2 years. Probability Of Bankruptcy is based on Macroaxis own algorithm and can be used by auditors, accountants, money managers, financial advisers, as well as day traders to evaluate unsystematic risk of a stock, fund or ETF.
Compare Amarin to competition

Amarin Probability Of Bankruptcy Assessment

Value  
 
Benchmark  Embed   Amarin Comparables 
Based on latest financial disclosure Amarin Corporation plc has Probability Of Bankruptcy of 93%. This is 131.31% higher than that of the Healthcare sector, and 56.37% higher than that of Drug Manufacturers - Other industry, The Probability Of Bankruptcy for all stocks is 117.7% lower than the firm.

Filter other Stocks by Probability Of Bankruptcy

Select Probability Of Bankruptcy Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Found 10 equities

Probability Of Bankruptcy

NVO NYQNovo Nordisk AS
1.0%
AGN NYQAllergan Inc
1.0%
TEVA NYQTeva Pharmaceutical Industries Limited
35.04%
ENDP NMSEndo International plc
43.14%
RDY NYQDr Reddys Laboratories Ltd
6.47%
TARO NYQTaro Pharmaceutical Industries Ltd
1.0%
ISIS NMSIsis Pharmaceuticals Inc
1.0%
UTHR NMSUnited Therapeutics Corporation
1.0%
DEPO NMSDepoMed Inc
35.12%
SCMP NGMSucampo Pharmaceuticals Inc
8.82%
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
   
Amarin Corporation plc has more than 93 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
SymbolAMRN
NameAmarin Corporation plc
InstrumentUSA Stock
CurrencyUSD - US Dollar
ExchangeNASDAQ General Markets
 

Other Amarin Fundamentals

Return On Asset(27.61) %
Profit Margin(108.97) %
Operating Margin(221.34) %
Current Valuation271.31 M
Shares Outstanding174.59 M
Shares Owned by Insiders3.93 %
Shares Owned by Institutions33.30 %
Number of Shares Shorted27.83 M
Price to Earning291.00 times
Price to Book341.94 times
Price to Sales3.72 times
Revenue47.83 M
Gross Profit14.44 M
EBITDA(105 M)
Net Income(52.12 M)
Cash and Equivalents135.43 M
Cash per Share0.78 times
Total Debt223.43 M
Current Ratio4.47 times
Book Value Per Share(0.40) times
Cash Flow from Operations(91.77 M)
Short Ratio16.90 times
One Year High2.09
One Year Low0.78
Earnings Per Share(0.53) times
Price to Earnings To Growth(0.02) times
Number of Employees185
Beta0.51
Market Capitalization183.32 M
Total Asset185.37 M
Retained Earnings(950.58 M)
Working Capital122.7 M
Current Asset158.04 M
Current Liabilities35.34 M
Z Score-7.0


 

Analytics

Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 

Research Modules

Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 

Services And Technology

Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 

Free Investor Tools

World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 

About Us

About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities